Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

NCT06071520 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT06071520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06071520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
June 30, 2023
Enrollment
50 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

primary immune thrombocytopenia